iCoreConnect Inc. (NASDAQ:ICCT – Get Free Report)’s share price traded up 1.2% during mid-day trading on Wednesday . The company traded as high as $0.18 and last traded at $0.17. 38,949 shares changed hands during mid-day trading, a decline of 99% from the average session volume of 4,996,410 shares. The stock had previously closed at $0.17.
iCoreConnect Stock Up 1.2%
The firm has a market cap of $356,556.00, a P/E ratio of 0.00 and a beta of -1.11. The firm’s 50-day moving average price is $1.71 and its 200 day moving average price is $2.07. The company has a debt-to-equity ratio of 7.93, a current ratio of 0.11 and a quick ratio of 0.11.
Insider Buying and Selling at iCoreConnect
In other iCoreConnect news, major shareholder Strategic Advisors L. Schonfeld sold 132,378 shares of the stock in a transaction on Monday, April 28th. The shares were sold at an average price of $2.26, for a total transaction of $299,174.28. Following the sale, the insider now directly owns 56,059 shares of the company’s stock, valued at approximately $126,693.34. This represents a 70.25% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 59.42% of the stock is currently owned by insiders.
Institutional Investors Weigh In On iCoreConnect
iCoreConnect Company Profile
iCoreConnect Inc, a cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. The company’s products include iCoreRx, a HIPAA compliant electronic prescription software; iCorePDMP, a solution that checks the patient’s Prescription Drug Monitoring Program (PDMP) history before prescribing controlled substances; iCoreVerify and iCoreVerify+, a HIPAA compliant SaaS solution that automatically retrieves a patients insurance eligibility breakdown to verify their benefits in advance of their appointment and on-demand; iCoreHuddle and iCoreHuddle+, a tool to instantly reveal the revenue potential of each patient; and iCoreCodeGenius, a medical coding reference SaaS solution.
Featured Stories
- Five stocks we like better than iCoreConnect
- Ride Out The Recession With These Dividend Kings
- Chime’s Smart IPO: Half the Valuation, Double the Strength
- What Are Dividend Challengers?
- Why Quantum Computing Inc. Is the Quiet Winner in Quantum Stocks
- What Do S&P 500 Stocks Tell Investors About the Market?
- 3 Catalysts in 7 Days: Archer’s Growth Story Just Accelerated
Receive News & Ratings for iCoreConnect Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iCoreConnect and related companies with MarketBeat.com's FREE daily email newsletter.